Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients - evidence of non-exosomal transport

Table 2 Clinico-pathological characteristics, viral DNA load and plasma concentration of miR-BART17 normalized with miR-cel-39 for samples from control donors

Control donors	Gender/age	Origin	Primary tumor	TNM	Histology	miR BART17 copy number/ml plasma
C1	M/54	Tunisia	larynx	T3N0M0	SCC	12
C2	M/53	Tunisia	larynx	T2N0M0	SCC	14
C3	M/59	France	larynx	T3N0M0	SCC	783
C4	F/60	France	larynx	T2N0M0	SCC	277
C5	M/55	France	larynx	T3N0M0	SCC	27
C6	M/448	France	hypopharynx	T3N0M0	SCC	30
C7	M/47	France	larynx	T3N0M0	SCC	174
C8	M/56	France	no tumor	na	na	18
C9	F/226	France	maxilary sinus	T4N1M0	SCC	435
C10	M/52	France	hypopharynx	T3N2M0	SCC	54

SCC: squamous cell carcinoma. C8 was a healthy donor. All other plasma samples except C10 were collected prior to treatment from patients bearing Head and Neck non-NPC carcinomas. The sample from patient C10 was collected under therapy.

ISSN: 1743-422X